Transcutaneous Auricular Neurostimulation (tAN) for Symptoms of Opioid Withdrawal

Completed · Not applicable

Conditions studied: Opioid-use Disorder, Opioid Withdrawal

In brief

Clinical performance data for transcutaneous auricular neurostimulation (tAN) as a method to aid in the reduction of symptoms associated with opioid withdrawal in order to support clinical substantial equivalence to a predicate device.

Key facts

Study ID
NCT04075214
Run by
Spark Biomedical, Inc.
People needed
35
Starts
2019-11-19
Expected to finish
2020-12-14
Last updated by the study team
2021-08-19

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.